Home
CYBN vs GSHR Comparison

CYBN vs GSHR Comparison

Compare CYBN & GSHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CYBN

GSHR

Machine Learning Prediction

ML Decision
CYBN
GSHR

Stock Information

Founded
CYBN 2019
GSHR 2024

Country
CYBN Canada
GSHR United States

Employees
CYBN N/A
GSHR N/A

Industry
CYBN Pharmaceuticals and Biotechnology
GSHR

Sector
CYBN Health Care
GSHR

Exchange
CYBN Nasdaq
GSHR NYSE

Market Cap
CYBN 180.4M
GSHR 205.8M

IPO Year
CYBN N/A
GSHR 2025

Fundamental

Price
CYBN $7.61
GSHR $10.12

Analyst Decision
CYBN Strong Buy
GSHR

Analyst Count
CYBN 4
GSHR 0

Target Price
CYBN $85.00
GSHR N/A

AVG Volume (30 Days)
CYBN 387.1K
GSHR 498.0

Earning Date
CYBN 08-07-2025
GSHR 01-01-0001

Dividend Yield
CYBN N/A
GSHR N/A

EPS Growth
CYBN N/A
GSHR N/A

EPS
CYBN N/A
GSHR N/A

Revenue
CYBN N/A
GSHR N/A

Revenue This Year
CYBN N/A
GSHR N/A

Revenue Next Year
CYBN N/A
GSHR N/A

P/E Ratio
CYBN N/A
GSHR N/A

Revenue Growth
CYBN N/A
GSHR N/A

52 Week Low
CYBN $4.81
GSHR $9.97

52 Week High
CYBN $13.88
GSHR $10.50

Technical

Relative Strength Index (RSI)
CYBN 46.51
GSHR N/A

Support Level
CYBN $7.35
GSHR N/A

Resistance Level
CYBN $7.85
GSHR N/A

Average True Range (ATR)
CYBN 0.60
GSHR 0.00

MACD
CYBN -0.10
GSHR 0.00

Stochastic Oscillator
CYBN 18.20
GSHR 0.00

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.

About GSHR GESHER ACQUISITION CORPORATION II ORD USD0.0001 CL A

Gesher Acquisition Corp II is a blank check company.

Share on Social Networks: